Description

The FibroACT Complete panel is a non-invasive blood test designed to evaluate the health of your liver and assess the risk or presence of liver fibrosis. By combining key liver enzymes, inflammation markers, and metabolic indicators, this panel helps detect liver damage early—before symptoms become severe. It is a valuable tool for monitoring chronic liver conditions, evaluating unexplained liver enzyme elevations, or assessing the impact of lifestyle factors such as alcohol use, obesity, or viral hepatitis.

Why This Test Is Important

Liver fibrosis can progress silently for years, eventually leading to cirrhosis or liver failure. Early detection allows for timely interventions—whether that’s lifestyle changes, medical treatment, or closer monitoring. FibroACT Complete gives you and your provider a clear picture of your liver’s current health status without the need for an invasive biopsy.

Biomarkers Included

Liver Enzymes & Function – Detects liver cell injury and overall liver function.

  • Alanine Aminotransferase (ALT) – Enzyme released when liver cells are damaged.
  • Aspartate Aminotransferase (AST) – Another key enzyme indicating liver injury.
  • Gamma-Glutamyl Transferase (GGT) – Sensitive marker for bile duct and alcohol-related liver disease.
  • Total Bilirubin – Measures waste product from red blood cells; high levels may indicate liver or bile duct problems.

Protein & Inflammation Markers – Identifies liver scarring and inflammation.

  • Alpha-2-Macroglobulin – Elevated in liver fibrosis and other inflammatory conditions.
  • Haptoglobin – May decrease with liver disease or hemolysis.
  • Apolipoprotein A1 – Can be reduced in chronic liver disease and inflammation.

Metabolic Markers – Evaluates metabolic risk factors linked to liver health.

  • Glucose – High levels may indicate insulin resistance or diabetes, both linked to fatty liver disease.
  • Triglycerides – Elevated levels increase risk for non-alcoholic fatty liver disease (NAFLD).
  • Cholesterol – Assesses lipid balance, which can affect liver metabolism.

Fasting Requirement:

8–12 hours fasting is recommended for accurate glucose and lipid results.

Take control of your liver health today—FibroACT Complete offers a clear, detailed view of your liver’s well-being and fibrosis risk without invasive procedures.